Apathy Evaluation Scale - Commercial Use

Commercial use includes any use by a commercial entity or any use funded by a commercial entity and includes any use in a commercial clinical study and/or patient care outside of a clinical study.

The fees associated with this Commercial License are as follows:

$20,000 for each commercial clinical study (a study directed or funded by a commercial entity)* *If the entity directing or funding the study has 50 or fewer employees AND the study involves 100 or fewer participants, the fee is reduced to $5,000 per study.

All other commercial uses are charged on a fee for use basis:

<250 uses $1,000
251 – 500 $2,500
501 - 1,000 uses $5,000
1,001 – 2,500 uses $9,000
2,501 – 5,000 uses $12,000
5,001 – 10,000 uses $15,000
>10,000 uses $20,000

Many translations are available upon request.

If you translate the Apathy Evaluation Scale ("AES") yourself, translations must use established linguistic validation methods including (but not limited to) cognitive interviews, translation, and back-translation by two bi-lingual speakers. All translations are the property of the University of Pittsburgh and You must provide any new translations You create to the University of Pittsburgh at IILA@pitt.edu and You agree to assign any rights You may have to such translations to the University of Pittsburgh.

If you have any questions regarding licensing, please use the "Request Info" form to submit an inquiry.

If your request is approved, you will receive a license agreement via DocuSign. Commercial licenses are not negotiable.